Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia.

Blood

Published: March 2012

Download full-text PDF	Source
http://dx.doi.org/10.1182/blood-2012-01-408047	DOI Listing

Publication Analysis

long-term chemoimmunotherapy

chemoimmunotherapy low-dose

low-dose fludarabine

fludarabine cyclophosphamide

cyclophosphamide high-dose

high-dose rituximab

rituximab initial

initial treatment

treatment patients

patients chronic

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!